ERBB2 and aneurysmal bone cyst: Following these findings, this study assessed and confirmed the prognostic value of RBC balanced immune-inflammatory parameters (LRR, NRR, MRR, and PRR) in hormone receptor-positive, HER2-negative ABC patients treated with CDKI.